ArticleJournal of orthopaedics2025
Does the cartilage proteome differ between osteoarthritic knees with varus and valgus deformities? Insights from proteomic analysis.
Article in Journal of orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To elucidate the proteome profile of cartilage tissue with two distinct phenotypes namely varus and valgus osteoarthritic (OA) knees in response to different loading conditions. Methods: Global proteomic analysis was performed on cartilage tissues isolated from weight-bearing and non-weight-bearing regions of varus (OA-varus) and valgus (OA-valgus) knees. The study group consists of eight samples in each category. Insolution digested cartilage tissue extracts were subjected to Q-exactive plus orbitrap quadrupole mass spectrometer for protein identifications. Downstream bioinformatic analysis were carried out to detect the altered proteins and pathways in OA-valgus and OA-varus groups. Results: Mass spectrometric analysis revealed that 645 and 742 proteins were identified from OA-valgus and OA-varus respectively. The differential analysis showed that 44 proteins were up regulated and 29 proteins were down regulated in OA-varus after assigning sample cutoff to 50 %. SOD2 was the top up regulated protein (log2FC = 2.688) and serum amyloid protein SAA2-SAA4 was the top down regulated protein (log2FC = -1.983) in OA-varus. KEGG pathway analysis revealed that upregulated proteins and unique proteins of OA-varus were enriched for complement and coagulation cascade and regulation of actin cytoskeleton. While the downregulated proteins of OA-varus (i.e. upregulation in OA-valgus) and unique proteins of OA-valgus were enriched for metabolic pathways including glycolysis, cholesterol metabolism, etc. Further GO analysis revealed that OA-varus proteins were enriched for immune responses and OA-valgus proteins were enriched for ECM related functions. Conclusion: Distinct proteomic profiles between OA-valgus and OA-varus knees were identified, with immune response pathways prominently in varus knees, and metabolic and structural pathways predominantly in valgus knees. These findings can inform targeted therapeutic strategies and OA management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.